Nialamide
NERVOUS SYSTEM
Also known as: nialamid, niamid, niamidal, niamide, niaquitil, niazin
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Nialamide is a drug catalogued in DrugCentral.
- ATC code: N06AF02 (Monoamine oxidase inhibitors, non-selective).
- Molecular formula: C16H18N4O2; molecular weight 298.35 g/mol.
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N06AF02 | NERVOUS SYSTEM › PSYCHOANALEPTICS › ANTIDEPRESSANTS › Monoamine oxidase inhibitors, non-selective |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Nialamide is on its molecule page.
| Molecular formula | C16H18N4O2 |
|---|---|
| Molecular weight | 298.35 g/mol |
| CAS number | 51-12-7 |
| InChIKey | NOIIUHRQUVNIDD-UHFFFAOYSA-N |
| PubChem CID | 4472 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is the chemical formula of Nialamide?
Nialamide has the molecular formula C16H18N4O2 and a molecular weight of 298.35 g/mol.
Browse: all drugs starting with N · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1907 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1256841 — compound record and bioactivity
- PubChem CID 4472 — chemical identifiers
- DrugBank DB04820 — drug record
- FDA UNII T2Q0RYM725 — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.